Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1881 1
1922 2
1949 1
1995 1
2000 2
2001 1
2002 1
2003 1
2004 1
2005 2
2006 4
2007 3
2008 1
2010 1
2011 2
2012 5
2013 6
2014 9
2015 11
2016 9
2017 5
2018 13
2019 4
2021 3
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 26137261

79 results

Results by year

Filters applied: . Clear all
Page 1
Feasibility of oral administration of S-1 as adjuvant chemotherapy in gastric cancer: 4-week S-1 administration followed by 2-week rest vs. 2-week administration followed by 1-week rest.
Yamatsuji T, Fujiwara Y, Matsumoto H, Hato S, Namikawa T, Hanazaki K, Takaoka M, Hayashi J, Shigemitsu K, Yoshida K, Urakami A, Uno F, Nishizaki M, Kagawa S, Ninomiya M, Fujiwara T, Hirai T, Nakamura M, Haisa M, Naomoto Y. Yamatsuji T, et al. Mol Clin Oncol. 2015 May;3(3):527-532. doi: 10.3892/mco.2015.500. Epub 2015 Feb 2. Mol Clin Oncol. 2015. PMID: 26137261 Free PMC article.
Randomized phase II study of S-1 dosing schedule for resected colorectal cancer.
Matsuda C, Uemura M, Nakata K, Shingai T, Nishimura J, Hata T, Ikenaga M, Takemasa I, Mizushima T, Kato T, Ikeda M, Ohue M, Murata K, Hasegawa J, Satoh T, Yamamoto H, Sekimoto M, Nezu R, Doki Y, Mori M. Matsuda C, et al. BMC Cancer. 2015 Jun 3;15:452. doi: 10.1186/s12885-015-1476-6. BMC Cancer. 2015. PMID: 26036466 Free PMC article. Clinical Trial.
Adherence and feasibility of 2 treatment schedules of S-1 as adjuvant chemotherapy for patients with completely resected advanced lung cancer: a multicenter randomized controlled trial.
Hata Y, Kiribayashi T, Kishi K, Nagashima M, Nakayama T, Ikeda S, Kadokura M, Ozeki Y, Otsuka H, Murakami Y, Takagi K, Iyoda A. Hata Y, et al. BMC Cancer. 2017 Aug 29;17(1):581. doi: 10.1186/s12885-017-3584-y. BMC Cancer. 2017. PMID: 28851314 Free PMC article. Clinical Trial.
Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.
Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi Y, Imamura H, Higashino M, Yamamura Y, Kurita A, Arai K; ACTS-GC Group. Sakuramoto S, et al. N Engl J Med. 2007 Nov 1;357(18):1810-20. doi: 10.1056/NEJMoa072252. N Engl J Med. 2007. PMID: 17978289 Free article. Clinical Trial.
A randomized phase III trial comparing S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC).
Oki E, Murata A, Yoshida K, Maeda K, Ikejiri K, Munemoto Y, Sasaki K, Matsuda C, Kotake M, Suenaga T, Matsuda H, Emi Y, Kakeji Y, Baba H, Hamada C, Saji S, Maehara Y. Oki E, et al. Ann Oncol. 2016 Jul;27(7):1266-72. doi: 10.1093/annonc/mdw162. Epub 2016 Apr 7. Ann Oncol. 2016. PMID: 27056996 Free PMC article. Clinical Trial.
Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.
Nashimoto A, Nakajima T, Furukawa H, Kitamura M, Kinoshita T, Yamamura Y, Sasako M, Kunii Y, Motohashi H, Yamamoto S; Gastric Cancer Surgical Study Group, Japan Clinical Oncology Group. Nashimoto A, et al. J Clin Oncol. 2003 Jun 15;21(12):2282-7. doi: 10.1200/JCO.2003.06.103. J Clin Oncol. 2003. PMID: 12805327 Clinical Trial.
79 results